Vaxart IMO is at least a $25 stock if their oral vaccine for COVID shows strong results by October 10th study completion date. Oral vaccines & boosters to only way to combat this crap, so a company like VXRT is pivotal. I'd argue at the 7 handle, they're undervalued. They do more than the COVID pill, but that pill will redefine their business if it's successful. And phase 1 crushed it. BULLISH VXRT